0910-AG20 201704 Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals--Second Phase Other Significant Previously Published in The Unified Agenda Completed Actions Undetermined Undetermined 21 CFR 210 21 CFR 211 21 U.S.C. 321 21 U.S.C. 351 21 U.S.C. 352 21 U.S.C. 355 21 U.S.C. 360b 21 U.S.C. 371 21 U.S.C. 374 42 U.S.C. 262 42 U.S.C. 264 No Withdrawn 06/08/2017 Yes Businesses None No Undetermined Yes Yes Paula Katz 0910 Food and Drug Administration FDA 301 796-6972 301 847-8742 paula.katz@fda.hhs.gov Suite 3037 (HFD-7), Center for Drug Evaluation and Research, WO 51, Room 4314, 10903 New Hampshire Avenue, Silver Spring MD 20993